Summary

To amend the Federal Food, Drug, and Cosmetic Act to establish user-fee programs for generic drugs and biosimilars. Read More

Status

This bill was introduced on Feb 8, 2012, in a previous session of Congress, but was not passed.

Bill Text

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to establish user-fee programs for generic drugs and biosimilars.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

This Act may be cited as the ``Generic Drug and Biosimilar User Fee Act of 2012''.

SEC. 2. TABLE OF CONTENTS.

The table of contents for this Act is as follows:

Sec. 1. Short title; table of contents. Sec. 2. Table of contents. TITLE I--FEES RELATING TO GENERIC DRUGS

Sec. 101. Short title; references in title; findings. Sec. 102. Authority to assess and use human generic drug fees. Sec. 103. Reauthorization; reporting requirements. Sec. 104. Sunset dates. Sec. 105. Effective date. Sec. 106. Amendment with respect to misbranding. Sec. 107. Electronic submission of applications. Sec. 108. Streamlined hiring authority of the Food and Drug Administration to support activities related to human generic drugs. TITLE II--FEES RELATING TO BIOSIMILAR BIOLOGICAL PRODUCTS

Sec. 201. Short title; references in title; finding. Sec. 202. Fees relating to biosimilar biological products. Sec. 203. Reauthorization; reporting requirements. Sec. 204. Sunset dates. Sec. 205. Effective date. Sec. 206. Savings clause. Sec. 207. Technical amendment; conforming amendment.

TITLE I--FEES RELATING TO GENERIC DRUGS

SEC. 101. SHORT TITLE; REFERENCES IN TITLE; FINDINGS.

(a) Short Title.--This title may be cited as the ``Generic Drug User Fee Amendments of 2012''. (b) References in Act.--Except as otherwise specified, amendments made by this title to a section or other provision of law...

Read Full Text

Sentiment Map

Select:

Nation

0 Supporting
0 Opposing
0% 0%

State: CA

0 Supporting
0 Opposing
0% 0%

District: 1st

0 Supporting
0 Opposing
0% 0%

Popularity Trend

Organizations Supporting

No organizations supporting yet.

Organizations Opposing

No organizations opposing yet.

Users Supporting

No constiutents supporting yet.

Users Opposing

No constituents opposing yet.

Bill Summary

To amend the Federal Food, Drug, and Cosmetic Act to establish user-fee programs for generic drugs and biosimilars.

H.R. 3987the Small Business Protection Act H.R. 3989the Student Success Act